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ABSTRACT 
WRAP53β is a WD40 domain protein with multifaceted capabilities in several biological 
processes in different cellular compartments. This includes transportation of the Survival of 
motor neuron (SMN) complex, small Cajal body-specific (sca) RNAs and the telomerase 
enzyme to Cajal bodies, as well as targeting of the E3 ligase RNF8 to DNA double-strand 
breaks (DSBs).  
In Paper I, we established WRAP53β as a novel player in the DNA damage response. 
WRAP53β is rapidly recruited to DNA lesions in an ATM, ATR, H2AX and MDC1 
dependent manner, and accumulates at the actual breaks and surrounding regions. WRAP53β 
interacts with the E3 ubiquitin ligase RNF8 and facilitates binding to MDC1 by 
simultaneously binding RNF8 and MDC1 via its WD40 domain. This is important for the 
downstream recruitment of the repair factors 53BP1, BRCA1 and RAD51. Knockdown of 
WRAP53β impairs DSB repair by both non-homologous end joining (NHEJ) and 
homologous recombination (HR), causing accumulation of DNA lesions and delayed 
recovery from G2/M cell cycle arrest.  
In Paper II, we introduced a sensitive method for analyzing the recruitment of repair factors 
and formation of protein-protein complexes at DNA lesions. By applying a fluorescence 
visualization technique called the proximity ligation assay (PLA), we observed accumulation 
of WRAP53β in close proximity to γH2AX in an ATM and ATR dependent manner, which 
we also confirmed by co-immunoprecipitation. Moreover, we visualized the interaction 
between MDC1 and RNF8 via PLA and confirmed that these interactions are dependent on 
WRAP53β and ATM. Our results also demonstrated that WRAP53β does not interfere with 
MDC1 phosphorylation by ATM but instead contributes directly to the MDC1 and RNF8 
interaction.   
In Paper III, we studied the role of overexpressed WRAP53β in DSB repair. We have 
demonstrated that overexpression of WRAP53β disrupts Cajal body formation, and at the 
same time, enhances the efficiency of DSB repair by HR and NHEJ. Accordingly, γH2AX 
foci were cleared faster in irradiated cells overexpressing WRAP53β.  We also observed 
increased ubiquitylation of histone H2AX and that this response was attenuated when the 
responsible enzyme RNF8 was knocked down. WRAP53β overexpressing cancer cells were 
also resistant to irradiation and several damage-inducing agents. Altogether, this indicates 
that overexpressed WRAP53β enhances RNF8-mediated ubiquitylation at DNA lesions and 
thereby increases the repair efficiency and improves cancer cell survival.  
  7 
In summary, we have identified WRAP53β as an essential player in the DNA damage 
response (DDR). We could verify its function at damage sites by using the PLA technique 
and furthermore showed overexpression of this protein enhances DNA repair efficiency.  
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1 LIST OF ABBREVIATIONS 
53BP1 
AP 
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ATR 
ATRIP 
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BER 
Bp 
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BRCC36 
BRCT 
CAB 
CB 
CDK 
CHD4 
Chk2 
CTCF 
DC 
DDR 
dHJ 
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DNA-PKcs 
DSB 
DSBR 
DUB 
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Ataxia-telangiectasia mutated 
Ataxia-telangiectasia and Rad3-related protein 
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DNA damage response 
Double Holliday junction 
Deoxyribonucleic acid 
DNA-dependent protein kinase, catalytic subunit 
Double-strand break 
Double strand break repair 
Deubiquitylating enzymes 
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FHA 
GAR1 
GRR 
HECT 
HERC 
 
HR 
HSP 
HU 
IR 
IRIF 
JMJD2A 
K6-polyUB 
L3MBTL1 
LIG3 
MDC1 
MIU 
MMR 
Mre11 
mRNA 
ncRNA 
NBS1 
NER 
NHEJ 
NOP56 
NOP58 
NSCLC 
Forkhead associated domain 
Glycien arginine rich protein 1 
Glycine-rich region 
Homology to E6AP carboxyl-terminus 
HECT and the RLD domain containing E3 ubiquitin protein 
ligase 2 
Homologous recombination 
Heat shock protein  
Hydroxurea 
Ionizing irradiation 
IR-induced foci 
Jumonji domain 2A 
Non-canonical lysine-6 linked ubiquitin chains 
Lethal(3)malignant brain tumor-like 1 
Ligase 3 
Mediator of the DNA damage checkpoint 1 
Motifs interacting with ubiquitin 
Mismatch repair 
Meiotic recomobination 11 
Messenger RNA 
Non-coding RNA 
Nijmegen breakage syndrome 1 
Nucleotide excision repair 
Non-homologous end joining 
Nucleolar protein 56 
Nucleolar protein 58 
Non-small cell lung cancer 
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NuRD 
OTUB1 
PAR 
PARP 
PCD 
PIAS 
PIKK 
PLA 
PNKP 
PRR 
PSMD4 
PST 
RAP80 
RBR 
RBR 
RING 
RNA 
RNF8 
RNP 
scaRNA 
scaRNP 
SDSA 
SMART 
SMA 
SMN 
snRNA 
snRNP 
Nucleosome remodeling and histone deacetylation 
OUT domain ubiquitin aldehyde-binding 1 
Poly(ADP-ribose) 
Poly(ADP-ribose) polymerase 
Programmed cell death 
Protein inhibitor of activated STAT 
Phosphatidylinositol 3-kinase-related kinase 
Proximity ligation assay 
Polynucleotide kinase/phosphatase 
Proline-rich region 
Proteasome 26S subunit non-ATPase 4 
Proline-serine-threonine 
Receptor-associated protein 80 
RNA binding region 
Ring between ring 
Really interesting new gene 
Ribonucleic acid 
Ring finger protein 8 
Ribonucleoprotein 
Small Cajal body-specific RNA 
Small Cajal body-specific RNP 
Synthesis-dependent strand annealing 
Simple modular architecture research tool 
Spinal muscular atrophy 
Survival of motor neuron 
Small nuclear RNA 
Spliceosomal small nuclear RNP 
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snoRNP 
SNP 
SSA 
SSB 
ssDNA 
STUbL 
SUMO 
SUV39H2 
TCP-1 
TDP2 
TERC 
TERT 
Tip60 
TOPBP1 
TRiC 
UBC13 
UDR 
UNRIP 
UPS 
USP3 
USP16 
UTR 
UV 
XLF 
WRAP53 
XRCC4 
WSTF 
Small nucleolar RNP 
Single nucleotide polymorphism 
Single-strand annealing 
Single-strand break 
Single-stranded DNA 
SUMO-targeted ubiquitin ligase 
Small ubiquitin-like modifier 
Suppressor of variegation 3-9 homologue 2 
T-complex protein 1 
Tyrosyl DNA phosphodiesterase 2 
Telomerase RNA component  
Telomerease reverse transcriptase 
60 KDa TAT-interactive protein 
Topoisomerase binding partner 1 
TCP-1 ring complex 
Ubiquitin-conjugating enzyme 13 
Ubiquitylation-dependent recruitment 
Unr-interacting protein 
Ubiquitin-proteasome system 
Ubiquitin-specific proteases 3 
Ubiquitin-specific proteases 16 
Untranslated region 
Ultraviolet 
XRCC4-like factor 
WD40-encoding RNA antisense to p53 
X-ray repair cross-complementing protein 4 
Williams syndrome transcription factor 
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XRCC1 X-ray repair cross-complementing protein 1 
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2 INTRODUCTION 
2.1 THE WRAP53 GENE 
The WD40-encoding RNA antisense to p53 (WRAP53) gene is located on chromosome 
17p13 just upstream of the p53 gene on the opposite strand in a head to head fashion and 
encodes at least 17 splice variants.  The gene has three alternative starting exons; 1α, 1β and 
1γ (1).  
1γ exon is located furthest upstream of the gene and overlaps the first intron of the p53 gene. 
However, there is no known function of this transcript. In contrast, transcription from 1α and 
1β leads to the production of two independent products with known activities, which gives 
the WRAP53 gene a dual function (1). Interestingly, the WRAP53 1α exon overlaps the first 
exon of p53 in an antisense fashion by up to 227 base pairs (bp) and transcription from this 
exon produces an antisense RNA, referred to as WRAP53α. Exon 1β is located further 
downstream, around 930 bp from p53 exon 1 and transcription from this exon produces a 
WD40 protein referred to as WRAP53β upon translation (other alias; WRAP53, TCAB1, and 
WDR79) (Figure 1) (1, 2).  
 
Figure 1: Schematic illustration of the WRAP53 gene with the antisense RNA termed WRAP53α and the WD40 
protein termed WRAP53β depicted. 
2.2 WRAP53α antisense RNA  
Sense-antisense gene pairs often consist of a protein-coding gene on the sense strand and a 
long non-coding RNA (ncRNA) encoding gene on the opposite antisense strand. Antisense 
transcripts have been shown to contribute to transcriptional control by stabilizing the sense 
messenger RNA (mRNA) (3).   
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The 5’untranslated region (UTR) of p53 is an important region for its mRNA stability (4). 
The WRAP53α transcript has a perfect complementary sequence to the 5’UTR of p53, which 
enables their interaction. Disruption of this interaction by knocking down WRAP53α or 
blocking formation of WRAP53α/p53 hybrids leads to decreased p53 RNA levels. 
Conversely, overexpression of WRAP53α increases p53 expression. Therefore, WRAP53α is 
an important stabilizer of the p53 mRNA, critical for the function of p53 in the DNA damage 
response and apoptosis (1).  
Recently, the CCCTC-binding factor (CTCF) was identified as a contributing factor in the 
WRAP53α-mediated p53 stabilization. CTCF is a multifunctional binding factor with several 
different functions, including transcriptional regulator, insulation (restricting enhancer-
promoter interaction) and chromatin organizer. Genome-wide association studies have shown 
widespread binding sites of CTCF to different promoters, enhancers and intergenic regions 
through its DNA-binding domain where one of its target sites is the p53 gene (5-7). 
Moreover, CTCF comprises a RNA binding region (RBR) that binds various transcripts 
genome-wide. Interestingly, one of them was WRAP53α RNA and direct interaction between 
CTCF and WRAP53α was important for the regulation of p53 RNA expression (8).  
2.3 WRAP53β 
2.3.1 WD40 proteins – domain and functions 
WD40 repeat proteins are highly abundant in eukaryotes and in humans there are 349 
predicted WD40 domain proteins based on a simple modular architecture research tool 
(SMART) database (9). The WD40 domain is characterized by the presence of repeated units 
of 44-60 amino acid residues where each unit ends with a tryptophan (W) and aspartate  (D) 
dipeptide (10). Each repeat contains a four-stranded antiparallel β-sheet that forms a strong 
hydrogen bond network, which together with the other repeats results in the stable folding of 
a β-propeller architecture. A WD40 propeller contains four to eight WD40 repeats (Figure 2) 
(11, 12). 
WD40 proteins are involved in many different biological processes such a cell cycle control, 
apoptosis, chromatin dynamics, gene expression regulation, histone methylation, genome 
stability, signal transduction, vesicular trafficking and cytoskeletal assembly (13, 14), where 
they serve as scaffolds for interacting partners. The three-dimensional β-propeller architecture 
of the WD40 domain enables interaction with partners from different angles via the top 
region, the bottom region and the circumference of the propeller. This allows formation of 
large and dynamic multi-protein complexes as well as interaction with DNA and RNA (15).  
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Figure 2: Schematic illustration of a β-propeller WD40 domain with eight repeats and four-stranded antiparallel 
β-sheet named a-b. Each color represents one WD40 repeat. 
2.3.2 Structure and folding of WRAP53β 
Folding of polypeptides into their three-dimensional structure is orchestrated by a highly 
organized proteostasis network that controls protein biogenesis, conformational maintenance 
and degradation. 
Chaperones conduct protein folding and are divided into different classes, including the heat 
shock proteins (HSP) 70, HSP90 and chaperonins. HSP70/90 are responsible for the vast 
majority of chaperone-mediated folding, which folds primarily the “easy” proteins. They 
mediate folding either as monomers or homodimers by interacting with sections of 
hydrophobic amino acid on nascent polypeptides, thereby preventing these sections from 
aggregating until the polypeptides are folded properly.  
Chaperonins fold proteins that are difficult to fold. These proteins have a more complex 
structure and are more sensitive to changes in the general cellular environment and 
chaperonins keeps the individual polypeptides of these proteins isolated by encapsulating 
them (16, 17). One such chaperonin is the T-complex protein 1 (TCP-1) ring complex 
(TRiC). This entity is an eight subunit ATP dependent type II chaperonin complex that 
functions to stabilize polypeptides with complex topologies in a non-stress inducible 
environment (Figure 3) (18, 19).  
Misfolding of proteins may cause different diseases. Fortunately, processes are available to 
discard the misfolded proteins by degradation through the ubiquitin-proteasome system 
(UPS) via the 26S proteasome that requires at least partially unfolded proteins. Degradation 
of misfolded proteins and folded proteins that are not degradable by the 26S proteasome may 
also occur via the less preferable autophagy machinery and/or lysosomal/vacuolar 
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degradation (20-23). Unfortunately, maintaining the proteostasis declines during aging, which 
leads to accumulation of misfolded proteins, increased deposition of aggregates, cellular 
toxicity and cell death. These outcomes may in turn lead to degenerative diseases such as 
Parkinson’s, Huntington’s and Alzheimer’s disease (Figure 3) (20, 24-28).  
 
Figure 3: Simplified schematic illustration of the proteostasis network. Polypeptides are folded into three-
dimensional structures through either HSP70/90 or chaperonin. Misfolded proteins are degraded through either 
proteasomal degradation or through autophagy.  
WD40 proteins are considered to have a complex topology and several WD40 proteins are 
folded by TRiC (18, 29). WRAP53β is a WD40 protein with seven predicted WD40 repeats a 
recent report demonstrated that WRAP53β is folded by TRiC (16, 30). Knockdown of any of 
the eight TRiC subunits resulted in reduced expression and aberrant localization of the 
WRAP53β protein while knockdown of the HSP70 family members did not have any effect. 
Loss of TRiC only affected the WRAP53β protein and not its mRNA expression.  In addition, 
TRiC binds the WD40 domain of WRAP53β in the cytoplasm and both the N- and C-termini 
of WRAP53β are dispensable for this interaction. Still, the C-terminus of WRAP53β is 
essential for proper folding and release from TRiC.  Impaired folding of WRAP53β by TRiC 
resulted in telomere shortening and was also linked to WRAP53β-associated dyskeratosis 
congenita, as further described below(16).  
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In addition to its WD40 domain, WRAP53β contains a N-terminal proline-rich region (PRR) 
and a C-terminal glycine-rich region (GRR) with unclear functions (Figure 1). PRR is known 
as a docking site for signaling modules (31-33), while GRR is a known RNA-binding domain 
involved in RNA recognition and processing (34).   
2.3.3 Role of WRAP53β in Cajal bodies  
WRAP53β is localized in both the cytoplasm and in the nucleus and is enriched in a nuclear 
organelle known as the Cajal body (CB) (35). 
CBs were described for the first time by Santiago Ramón y Cajal in 1903 as small spherical 
organelles with a size range between 0.2-2µm only visible in the nucleoplasm (36). The 
number of CBs varies among tissues (1-10 per nucleus), where the number and the size of 
CBs correlates with the metabolic and proliferative activity of the tissue and being mostly 
abundant in cells with high splicing and transcription rates (37, 38). Furthermore, CBs are 
highly dynamic and mobile structures that move to and from nucleoli. As such, they are 
capable of merging into larger structures and separating into smaller bodies (39). The lack of 
a phospholipid membrane barrier makes it possible for many factors to move in and out from 
CBs, which gives them a dynamic structure and accumulation capacity for many factors (40).  
CBs are highly concentrated in a variety of factors, including SMN, ribonucleoproteins 
(RNP) complexes such as spliceosomal small nuclear RNPs (snRNPs), small nucleolar RNPs 
(snoRNPs), small Cajal body-specific RNPs (scaRNPs), components of the telomerase RNP 
complex, the p80 protein Coilin, WRAP53β, many ncRNAs from the families of small 
nuclear RNA (snRNA) and scaRNA. All of these factors are important for the maturation of 
snRNPs, snoRNPs and the telomerase RNP, as well as for splicing and telomere maintenance 
(38). It is belied that CBs function as a compartment that increases the efficiency of these 
processes by concentrating all factors involved. Indeed, cells survive in the absence of CBs, 
probably because these essential processes can still take place in the nucleoplasm but to a 
lower efficiency (41-43).  
2.3.3.1 Maintenance of Cajal bodies  
Several studies have shown that WRAP53β is highly enriched in CBs in several cell lines and 
is a vital factor in the maintenance and localization of factors to this organelle (30, 35, 44). 
Interestingly, cells lacking WRAP53β displays collapsed CBs, are unable to reform and the 
CB factors coilin and SMN are mislocalized to nucleoli. Loss of all CBs is also observed in 
cells absent of coilin, while loss of SMN only reduces the number of CBs (35).  
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CBs are also disrupted by overexpression of high levels of exogenous WRAP53β, which may 
be due to an adverse effect on the endogenous WRAP53β function by self-association 
between exogenous and endogenous WRAP53β (35). Similar results have been reported for 
overexpression of coilin (45). Thus, WRAP53β, together with coilin, maintains the structure 
and formation of CBs.  
2.3.3.2 Localizing the SMN complex to Cajal bodies  
SMN is a 38 kDa protein encoded by the two genes SMN1 and SMN2 that plays an important 
role in the cytoplasmic assembly of splicing snRNPs (46, 47). SMN oligomerizes through its 
self-association domain and interacts via its Tudor domain with RG (motifs rich in arginine 
and glycine) boxes of coilin and Sm proteins (48, 49). However, SMN does not assemble 
snRNPs on its own but function together with at least nine other proteins, including Gemins 
2-8, Unr-interacting proteins (UNRIPs), in a complex called the SMN complex (50). 
Our group showed that WRAP53β facilitates the import of the SMN complex from the 
cytoplasm to the nucleus by mediating interaction between SMN and the nuclear pore 
receptor of Importin-β and furthermore, the localization of the SMN complex to Cajal bodies 
by mediating interaction between SMN and coilin (35). 
2.3.3.3 Localizing scaRNAs to Cajal bodies 
ScaRNA are ncRNAs and this RNA family consists of at least 24 members that are 
specifically localized in the CBs where they guide the factors responsible for the post-
transcriptional modification of snRNA during the maturation process of snRNPs. ScaRNAs 
are divided into three distinct classes: C/D box, H/ACA box and a mixture of both motifs, 
which is based on their guide-specificity, sequence element and structural motifs (51). The 
C/D scaRNAs comprise two sequence motifs called the C (UGAUGA) and D (CUGA) box 
and guide methylation of snRNA. The H/ACA scaRNA, are comprised of the H (ANANNA) 
and the ACA motifs, which guides the isomerization of uridine into pseudourine. The C/D 
scaRNA brings a complex of four proteins: the nucleolar protein 56 (NOP56), NOP58, 
NHP2L1/15,5K and the methyltransferase fibrillarin, the latter of which is responsible for the 
2´-O-methylation of snRNAs. The H/ACA scaRNAs carries a complex of four other proteins: 
the Glycine arginine rich protein 1 (GAR1), NHP2, NOP10 and the pseudouridine synthase 
dyskerin. Both C/D and H/ACA scaRNAs direct the associated enzymes to snRNAs via 
sequence complementary (52, 53). The modified sites on snRNAs are well conserved and 
distributed in functionally important loci involved in RNA-RNA and RNA-protein 
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interactions. Thus, modification of snRNAs alters their structure and enhances interactions 
with RNA and proteins important for their function in pre-mRNA splicing (Figure 4) (54).  
The H/ACA and the mixture H/ACA-C/D scaRNAs contain a Cajal body localization box 
(CAB box, a tetranucleotide sequence ugAG) that targets them to CBs (51, 55). WRAP53β 
interacts directly with this CAB box and thereby recruits scaRNA to CBs. Depletion of 
WRAP53β or mutation in the scaRNA CAB box that obstructs their interaction leads to 
mislocalization of the scaRNA to the nucleoli (44). The C/D scaRNA, on the other hand, does 
not contain the CAB box, and therefore it remains unclear how C/D scaRNA are recruited to 
the CBs. Although it has been shown that WRAP53β interacts with C/D scaRNA, but 20-fold 
less efficiently compared to H/ACA scaRNA (44, 56). Yet it has been shown recently that the 
main interaction partner with the C/D scaRNA is coilin, which is involved in the processing 
of certain C/D scaRNAs. However, another research group have shown that C/D scaRNAs 
instead contain a GU- or UG-dinucleotide-rich repeat sequences, called the G.U/U.G wobble 
stem and is predicted to form a terminal stem-loop of the RNA apical hairpin. This novel 
Cajal body localization element is critical for the interaction of C/D box scaRNPs with 
WRAP53β, and their subsequent localization to Cajal bodies (figure 4) (56-59).   
In addition to binding the CAB motif of H/ACA scaRNAs, WRAP53β also interacts with 
CAB box-containing AluACA RNAs (60). Full-length Alu elements are about 300 nt long 
with two monomer units (left and right arms) that are present in more than one million copies 
in the human genome in a non identical sequence (60, 61).  The AluACA RNAs are 
processed from intron-encoded Alu RNAs and mature AluACA RNAs are structurally 
similar to H/ACA scaRNAs and associate with the H/ACA core proteins: NOP10, NHP2, 
GAR1, and dyskerin. However, H/ACA scaRNA that only carries one CAB box on either of 
the 3’ or 5’ hairpins, the 3’ hairpin of Alu ACA RNAs carry two CAB boxes, which interacts 
with WRAP53β and accumulate in the nucleoplasm. . Moreover, unlike H/ACA scaRNAs, 
which accumulate in Cajal Bodies, AluACA RNAs accumulate in the nucleoplasm. It is not 
known if the differentially arranged CAB boxes contribute to the different subcellular 
localization of the H/ACA scaRNPs and AluACA RNPs and what the main function of the 
AluACA RNPs is (60).  
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Figure 4: An illustration of a H/ACA box (A) and C/D box (B) scaRNA. A. Targeted snRNA (red) interacts 
with the H/ACA scaRNA and becomes pseudouridylated (Ψ) by dyskerin. WRAP53β interacts with the CAB 
motif and facilitates transportation of scaRNAs to CBs. B. Targeted snRNA (red) interacts to complementary 
sequence of C/D scaRNA located in between the C and D box and becomes 2´-O-methylated by fibrillarin.  
2.3.3.4 Localizing the telomerase complex to Cajal bodies and telomeres  
Telomeres consist of short repetitive TTAGGG hexanucleotide units that span over 2-15 kb 
at the end of chromosomes and are ended with a G-rich 3’ single-stranded region of about 
100-200 bp (62). The overhanging 3’ single-stranded region invades the double-stranded 
region by creating a t-loop structure that acts as a closed structure to prevent chromosomal 
end fusion (63). In addition, the six subunit based shelterin complex mediates the t-loop 
structure by capping the double-stranded and single-stranded telomeric DNA (62). Telomeres 
lose about 100-200 bp after each full cell cycle, which gives primary human cells a lifespan 
of 60-80 population doublings before they become senescent and die by apoptosis to prevent 
genomic instability (64, 65). Unfortunately, cancer cells have the ability to counteract 
telomere shortening and evade senescence by reactivating the telomere enzymes (66). 
The telomere enzyme synthesize the addition of the telomeric repeats on telomeres and 
consist of the enzyme telomerase reverse transcriptase (TERT) and the telomerase RNA 
component (TERC).  
TERC is a 451 nt long H/ACA containing scaRNA that acts as a template for DNA synthesis 
(67, 68). As mentioned earlier, the H/ACA box provides the assembly of the associated 
proteins such as dyskerin and the binding of dyskerin to TERC is important for the stability 
of TERC and the biogenesis of the telomerase RNP. However, there is no evidence that 
dyskerin uses TERC as a guide for pseudouridylation of target RNAs (69, 70). TERC also 
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contains the CAB box that allows interaction with WRAP53β and thereby enables targeting 
of TERC (in association with the active telomerase enzyme) to CBs and further on to 
telomeres by WRAP53β, which is essential for telomere elongation. The assembly of TERC 
into an active telomerase enzyme is independent of WRAP53β and most likely occurs prior 
to binding to WRAP53β. Knockdown of WRAP53β or mutations in the CAB box of TERC 
does not affect the levels of TERC but disrupts targeting of TERC and the associated 
complex to CBs and telomeres, which leads to progressive telomere shortening. Furthermore, 
WRAP53β associates with all telomerase factors including TERT and dyskerin. The 
association with TERT is believed to be mediated through the interaction to TERC since the 
association between TERT and WRAP53β was lost upon RNase A treatment. However, it is 
believed that the interaction with dyskerin is based on protein-protein interaction due to its 
insensitivity to the RNase A treatment (Figure 5) (30, 71, 72).
 
Figure 5: WRAP53β targets TERC, Dyskerin and TERT to CBs by interacting with the CAB box of TERC and 
subsequently transport telomerase to telomeres. 
2.3.4 Role of WRAP53β in inherited diseases 
2.3.4.1 Dyskeratosis congenita  
Telomere biology disorders include several different diseases. These overlapping conditions 
are cause by inherited mutations in factors involved in different aspects of telomere 
maintenance. Dyskeratosis congenita (DC) is the most common telomere biology disorder, 
characterized by bone marrow failure, premature aging, cancer predisposition, skin 
pigmentation, nail dystrophy and oral premalignant leukoplakia. The most frequent tumors in 
DC patients are myelodysplastic syndrome, acute myelogenous leukemia and the solid 
tumors squamous cell carcinoma of the head/neck and anogenital cancer (73, 74). DC 
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patients also display very short telomeres and impaired stem cell function due to defective 
and insufficient telomere maintenance. As many as nine genes have been identified mutated 
in patients with DC where the different genes are inherited through X-linked, autosomal 
recessive or autosomal dominant patterns (Figure 6) (73, 75, 76).     
 
Figure 6: A scheme of proteins with genetic abnormalities associated with DC and their function in telomere 
maintenance.  
Germline mutations in WRAP53β cause DC and so far four missense mutations in 
WRAP53β have been identified in two patients, inherited in an autosomal recessive fashion. 
The first patient displayed mutations in exon 2 and 8 (F164L and R398W, respectively) of 
WRAP53β and the second patient had mutations in exon 7 and 9 (H376Y and G435R, 
respectively). This caused severely reduced protein expression of WRAP53β, especially in 
the nuclear compartment, while the mRNA levels of WRAP53β were unaffected, indicating 
that the protein is downregulated post-translationally in these patients. Since the mutated 
residues all locate in the highly conserved WD40 domain of WRAP53β they are believed to 
impair the function of this domain. Indeed, mutations in WRAP53β prevent TRiC-mediated 
folding resulting in reduced stability of WRAP53β protein and its mislocalization within the 
cell, i.e. inability of WRAP53β to enter the nucleus. As a consequence, TERT is not localized 
to CBs (instead accumulate in nucleoli) and telomere elongation is disrupted (16, 77).  
2.3.4.2 Spinal muscular atrophy  
Spinal muscular atrophy (SMA) is a neurodegenerative disorder where patients have 
progressive degeneration of spinal cord anterior horn α-motor neurons, muscle atrophy and 
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motor impairment due to homozygous deletion or mutation in the SMN1 gene. This condition 
is the leading genetic cause of infant mortality worldwide and is further divided into four 
different classifications (SMA I-IV) that are based on age of onset and disease severity. SMA 
type I is the most common and severe variant with signs of the disease appearing soon after 
birth (49, 78, 79).   
The human genome contains two genes encoding the SMN protein, SMN1 and SMN2, due to 
a large inverted duplication located in chromosome 5q. These two genes are almost identical 
and only differ only in a critical single nucleotide in exon 7 (C to T transition) of SMN2 that 
disrupts an exon splicing enhancer. This leads to a potential redirection towards alternative 
splicing, where exon 7 is excluded from SMN2-derived mRNA transcripts, resulting in a 
truncated SMN protein that is rapidly degraded (80-84). Although a small portion of the 
mRNAs produced from SMN2 includes exon 7 and give rise to the full-length SMN protein, 
the SMN2 gene cannot compensate for the loss of SMN protein caused by deletions or 
mutations in SMN1. Interestingly, multiple copies of the SMN2 gene may exist due to the 
instability of chromosome 5q caused by duplication and the amount of these copies correlate 
with disease severity, where higher copy number correlates with milder disease variants (85).  
Patients with five SMN2 copies have been found to completely compensate for homozygous 
SMN1 deletion thus preventing SMA development (86).   
Why the motor neurons in the spinal cord are selectively killed in SMA patients is unclear. It 
has been suggested that motor neurons have higher energy requirements and express SMN at 
the levels of demand while other tissues express more than necessary (87, 88). Moreover, 
SMN is essential for the assembly of the heptameric Sm ring on snRNAs and thus plays a key 
role in the splicesomal snRNP biogenesis pathway, which could be of particular importance 
for motor neurons. Accordingly, both animal and cell culture models have displayed a 
correlation between reduced snRNP assembly and disease severity in motor neuron 
degeneration. It has also been shown that the targeting of SMN and coilin to CBs is defective 
in SMA type I motor neurons (89-92). Our data indicate that WRAP53β may be involved in 
the latter scenario, since the WRAP53β-SMN interaction is disrupted in fibroblasts from 
SMA type I patients, which could contribute to the failure of SMN and coilin in localizing to 
CBs (35).  
2.3.5 Role of WRAP53β in cancer  
WRAP53β is overexpressed in several different cancer cell lines of different origin and its 
overexpression promotes carcinogenic transformation of NIH3T3 cells. Moreover, cancer cell 
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lines become apoptotic through the mitochondrial pathway when WRAP53β is knocked 
down while normal cells are unaffected (93). This indicates that WRAP53β has oncogenic 
properties when overexpressed and that cancer cells get addicted to WRAP53β (oncogenic 
addiction). Furthermore, WRAP53β is overexpressed in primary esophageal squamous cell 
carcinoma, non-small cell lung cancer (NSCLC), primary nasopharyngeal carcinoma and 
rectal cancer (94-97). Knockdown of WRAP53β in NSCLC and head and neck cancer cell 
lines reduced size of the tumors formed when these were grafted into mice (95, 96).  
As mentioned earlier, WRAP53β is an important factor in telomere elongation, which could 
partially explain its oncogenic properties. After all, constant telomerase activation is what 
immortalizes 90% of all human cancers (98). On the other hand, mutations in both alleles of 
WRAP53β cause DC, which indicates that WRAP53β acts as a tumor suppressor rather than 
an oncogene. In line with this, reduced expression of WRAP53β in epithelial ovarian, breast 
and head and neck cancer correlates with poor patient survival (99, 100). Furthermore, single 
nucleotide polymorphisms (SNPs) in the WRAP53 gene increase the risk of breast and 
ovarian cancer development (101, 102). 
Together this indicates that WRAP53β may have different functions in cancer depending on 
cancer types or stage of tumor development, which influences whether WRAP53β should act 
as a tumor suppressor or as an oncogene. Moreover, the subcellular localization of WRAP53β 
is of importance for its cancer susceptibility properties, since loss of nuclear but not 
cytoplasmic WRAP53β is correlated with reduced survival and radioresistance in head and 
neck cancer patients (103).  
2.4 THE DNA DAMAGE RESPONSE 
About 50,000 DNA lesions occur daily where the majority are base modifications (104, 105). 
However, about ten of these lesions are DSBs, which are considered to be the most cytotoxic 
form of DNA damage and require a more sophisticated and complex reparation machinery. 
Efficient and proper repair of all different types of damage is required for maintaining the 
genomic integrity and an ineffective repair may lead to mutations, cell death and severe 
diseases such as cancer, neurodegeneration, immunodeficiency and radiosensitivity (106). 
The majority of DNA lesions arise from endogenous activities, including hydrolytic 
reactions, non-enzymatic methylations, byproducts produced from oxidative respiration or 
through redox-cycling events. Some also arise due to physiological processes such as 
mismatches during DNA replication or due to unsuccessful topoisomerase I and II activities 
(107).   
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DNA damage also arises by exogenous agent, including ultraviolet (UV) light. Even though 
the ozone layer removes most of the dangerous UV rays, residual UV-A and UV-B from 
extensive sun exposure can induce approximately 100,000 lesions per exposed cell and hour 
of sunlight. Additionally, exposure to ionizing irradiation (IR) from for example radon gas, 
tobacco smoke and overcooked meat induce DNA damage that is connected to different 
cancer types (108, 109).  
To counteract the threats posed by DNA damage, cells have developed several repair 
mechanism that activates a signaling cascade collectively called the DNA damage response 
(DDR). The DDR serves to maintain genomic integrity by detecting DNA lesions, signaling 
their presence and promoting repair (110, 111). However, the DDR facilitates different repair 
pathways depending on the type of lesion acquired and the majority of lesions are repaired by 
catalytic events involving multiple proteins. The mismatch repair (MMR) is an important 
repair system during DNA replication and recombination that corrects mismatches of bases 
by triggering a single-strand incision and then resynthesizing by DNA polymerase (112). 
Meanwhile, the base-excision repair (BER) pathway corrects damage of a single nitrogenous 
base that is recognized and removed by a DNA glycosylase enzyme to produce an apurinic-
apyrimidinic (AP) site. The site is further processed by an AP endonuclease and other factors 
to prepare the strand to be resynthesized by a DNA polymerase (113). Helix-distorting base 
lesions caused by UV light is repaired by nucleotide excision repair (NER), where the repair 
involves the removal of about 22-30 oligonucleotides creating a stretch of single-stranded 
DNA (ssDNA), which is then refilled by a DNA polymerase (114). DSBs are repaired by two 
repair systems called homologous recombination (HR) and non-homologous end joining 
(NHEJ) including several subtypes as further described below.  
2.4.1 DNA double-strand breaks  
DSBs arise when the phosphodiester bond is broken simultaneously in close proximity on 
opposite DNA strands. This could be extremely toxic for the cell if not repaired since it for 
example may lead to genome rearrangement. A DSB requires a more complex repair system, 
since most probably some nucleotides are lost due to the damage, while single-strand DNA 
breaks (SSBs) still have a physically undamaged strand that can be used as template to restore 
the damage strand (115).  
DSBs may occur naturally during meiotic recombination and during V(D)J recombination, 
the latter being an important maturation step of the immune system. However, DSBs arise 
also at sites of collapse of the DNA replication forks or due to topoisomerase II cleavage 
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(116, 117). Several exogenous sources may also induce DSB such as topoisomerase 
inhibitors, DNA damage inducing agents, radiomimetic drugs and IR (118).  
Upon DSB induction, several factors are involved in sensing the region where the damage 
has occurred and activates the signal transducers that amplify and transduce signals to 
downstream effectors. Eventually, mediators are activated by posttranslational modification 
by different sensors and transducers to coordinate the spatio-termporal regulation of all 
different factors involved in the DDR. This is done by promoting activation, maintaining 
recruitment and controlling the association of repair factors with damaged DNA. The 
transducers activate different downstream effectors depending on the response required such 
as cell cycle arrest effectors, DNA repair effectors (e.g., NHEJ or HR) programmed cell death 
(PCD) or apoptosis effectors (119).   
2.4.2 DNA damage signaling  
Since there are different pathways available  (e.g., NEHJ and HR) for DSB repair, the 
appropriate sensor needs to be activated to promote further signaling and subsequently 
promote the required repair pathway for the most efficient repair. However, it is yet not 
directly known how a particular DSB promotes the recruitment of one over another DNA 
damage-sensing factor. Even so, it is believed that several factors may be attributed to the 
choice of the sensor such as the cell cycle where the HR pathway can only be utilized during 
the S/G2 cell cycle phase. This is due to the requirement of a sister chromatid as a template 
sequence whereas the NHEJ pathway repairs throughout the cell cycle (120).  
The poly(ADP-ribose) polymerase (PARP) proteins PARP1 and PARP2 can sense both 
single- and double-stranded DNA damage, whereas PARP3 predominately responds to DSBs 
(121). The roles of PARPs in SSB involve activation of their enzymatic activities and the 
synthesization of poly (ADP)-ribose (PAR) chains on themselves and other proteins. In this 
manner, PARPs promote the recruitment of the X-ray repair cross-complementing protein 1 
(XRCC1) and the DNA ligase 3 (LIG3) (122-124). Although their importance in DSBs is less 
studied and highly debated, recent data has suggested that PARP1 is involved in HR repair 
pathways of hydroxurea (HU)-mediated collapsed replication forks by recruiting the meiotic 
recombination 11 (Mre11) nuclease and initiating end resection activity (125, 126). On the 
other hand, PARP3 drives repair towards the NHEJ repair pathway by preventing excessive 
end-resection mediated by Mre11 and repair by HR (121). 
The Ku heterodimer is comprised of Ku70 and 80 and acts as a sensor for the NHEJ pathway 
by interacting with free DNA ends. It is believed that the sensing capability of Ku in NHEJ is 
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based on its high affinity for free DNA ends. The high DNA binding affinity is independent 
of DNA sequence and allows for a rapid binding (about 5 seconds), which is important for 
stabilizing the DNA ends and for recruiting downstream NHEJ factors (127, 128). 
The MRN complex is the major sensor of DNA DSBs and is implicated also in DNA 
replication fork restart, telomere maintenance, signaling to the cell cycle checkpoints and 
meiosis (129, 130). The complex is comprised of three proteins: Mre11, RAD50 and the 
Nijmegen breakage syndrome 1 (NBS1). The Mre11/RAD50 complex interacts with the 
damaged DNA ends as a heterotetramer through Mre11. The DNA ends are brought in close 
proximity by RAD50 globular domains from which anti-parallel coiled coil structures extend 
to Zn-hook domains. This process facilitates RAD50 dimerization (131). NBS1 on the other 
hand recruits and activates the ataxia-telangiectasia mutated (ATM) kinase, which mediates 
downstream signaling (132, 133).  
2.4.2.1 Phosphorylation-mediated signaling  
Phosphorylation mediated signaling is coordinated by the apical phosphatidylinositol 3-
kinase-related kinases (PIKKs): ATM, ataxia-telangiectasia and Rad3-related protein (ATR) 
and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). These three kinases 
phosphorylate serine or threonine residues followed by a glutamine residue (S/TQ). Several 
hundred potential substrates have been identified for ATM and ATR (134, 135), while DNA-
PKcs itself is the only relevant DNA-PK substrate identified so far in vivo, but in vitro this 
latter enzyme phosphorylates several DDR factors (136-138). All three kinases mediate the 
phosphorylation of the histone variant H2AX on serine 139 (referred to as γH2AX), which is 
one of the earliest events in the DDR cascade (139, 140). ATR is most important for H2AX 
phosphorylation during replication stress or following DNA end resection (141). ATR is 
recruited together with its interaction partner ATR-interacting protein (ATRIP) and is then 
activated by the topoisomerase binding partner 1 (TOPBP1) (142, 143). It has also been 
shown that the MRN complex mediates ATR signaling where RAD50 is phosphorylated by 
ATR even though the MRN complex primary function is to recruit ATM to DSBs. 
Phosphorylated RAD50 is an important factor for DNA replication restart by promoting 
loading of cohesin at the site of damage (131). While ATR primarily promotes γH2AX 
formation in replication stress, ATM is the major player in phosphorylating H2AX in 
response to DSBs. Yet DNA-PKcs function redundantly and overlap in γH2AX formation 
(144, 145). 
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ATM is present in its inactive form as a non-covalently linked dimer (146). ATM becomes 
activated upon DSB formation by dimer disassociation into monomers, which leads to 
activation of its enzymatic activity and autophosphorylation at serine 1981. Eventually ATM 
is recruited to DSB by the MRN complex (147). However, besides autophosphorylation and 
the MRN complex, the acetyltransferase 60 KDa TAT-interactive protein (Tip60) is required 
for maximal ATM activation where Tip60 is recruited to DSB in a complex with ATM by 
interaction with H3K9me3 and H3K36me3 leading to acetylation of ATM on lysine 3016, 
histone H4 and histone H2A (148-151). 
The human nucleosome consists of a histone octameric core comprised of four different 
histone types: H2A, H2B, H3 and H4. The histone types constantly undergo different 
posttranslational modifications such as phosphorylation, ubiquitination, sumolytion, 
PARylation, methylation and acetylation (152). The dynamic combination of histone 
posttranslational modification influences gene expression, DDR signaling and repair (153, 
154). H2AX is a member of the H2A family and accounts for about 10% of total H2A 
molecules in human fibroblasts and varies between 2-25% in other cell types. In addition, 
H2AX has a longer C-terminal tail with a conserved SQ phosphorylation motif as compared 
to H2A. The discovery of the SQ site as responsive to DNA damage-induced phosphorylation 
was a crucial step in establishing H2AX as an important player in the DDR (155).  
As mentioned earlier, γH2AX formation requires phosphorylation of H2AX at serine 139 by 
the PIKKs but H2AX needs to be methylated before being phosphorylated. The suppressor of 
variegation 3-9 homologue 2 (SUV39H2) is a SET containing methyltransferase that 
methylates H3K9 and has been shown to dimethylate H2AX on lysine 134. Loss of 
methylated H2AX has revealed substantially lower levels of γH2AX formation and 
expression and also leads to reduced affinity between the PIKKs and H2AX. Therefore, ATM 
and ATR at least need to bind to H2AX K134 to be able to mediate the phosphorylation at 
S139 for γH2AX formation (156). 
Formation of γH2AX at DSBs reaches its maximum within minutes post-damage and can be 
detected up to 2 mega bases away from the DSB. This is important for facilitating focus 
formation, retention of repair proteins and chromatin changes at DSBs (157-159). Even 
though there is evidence indicating that γH2AX is an important factor in DNA damage 
signaling in both HR and NHEJ pathways, it is not essential for the initial localization of 
DDR factors such as the p53 binding protein 1 (53BP1), breast cancer 1 (BRCA1) or the 
MRN complex. Additionally, only mild defects in DNA damage checkpoint controls and 
DNA repair processes were observed in H2AX deficient cells.  Therefore, it is believed that 
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γH2AX is important for optimizing repair efficiency by concentrating proteins in the vicinity 
of DSBs (160-162).  
Interestingly, H2AX may also be phosphorylated on tyrosine 142 by the Williams syndrome 
transcription factor (WSTF) remodeling factor kinase, which seems to be important in 
chromatin remodeling (163, 164). γH2AX is eventually dephosphorylated when the lesion 
has been repaired and several phosphatases such as PP1, PP2A, PP4 and WIP1 are involved 
in this dephosphorylation. However, a portion of the phosphorylated H2AX is also evicted 
from the nucleosome by histone exchange (165). 
Mediator of the DNA damage checkpoint 1 (MDC1) is a large protein with five domains: 
forkhead associated domain (FHA), SDT, TQXF, proline-serine-threonine (PST) and BRCA1 
carboxyl-terminus (BRCT), which enable it to interact with several DDR factors. The tandem 
BRCT domain mediates phosphorylation-dependent interaction and is located in the C-
terminus of MDC1. The BRCT domain of MDC1 directly binds γH2AX, which enables 
MDC1 to act as an adaptor protein that interacts with other proteins through its many other 
domains (166, 167). The PST domain is the least conserved one and little is known about its 
function. This domain is not required for MDC1 accumulation at DSBs, its function in 
mediating accumulation of downstream DDR factors, nor for activation of HR or NHEJ 
(168). The FHA domain in the N-terminus of MDC1 mediates the interaction with ATM, the 
checkpoint kinase 2 (Chk2) and RAD51 (169). ATM phosphorylates the TQXF motif of 
MDC1, which facilitates interaction of MDC1 with the E3 ubiquitin ligase ring finger protein 
8 (RNF8). Chk2 phosphorylates the SDT domain, which facilitates interaction with NBS1, 
important for the MRN complex retention at DBSs. Interaction with ATM, NBS1 and 
γH2AX enables MDC1 to directly or indirectly mediate the recruitment and retention of 
activated ATM and the continuous phosphorylation of H2AX located more distant to the 
damage site (170-173).  
MDC1 residence time at the damage site is controlled by small ubiquitin-like modifier 
(SUMO)ylation mediated by protein inhibitor of activated STAT (PIAS)1/4. SUMOylated 
MDC1 is recognized by the SUMO-targeted ubiquitin ligase (STUbL) RNF4 that 
ubiquitylates MDC1 and this modification is recognized by proteasome 26S subunit non-
ATPase 4 (PSMD4) and leads to proteasomal degradation (174, 175).  
The PIKKs also phosphorylate effector molecules that regulate cellular processes. These 
include transcription, senescence, apoptosis and delayed cell cycle progression. Chk1 and 
Chk2 are two well characterized substrates of ATR and ATM, respectively (176). Chk1 is 
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important for the activation and maintenance of the G2/M checkpoint whereas Chk2 is 
mainly important for the G1/S checkpoint (177). Both entities act by reducing the cyclin-
dependent kinase (CDK) activity to mainly slow down or arrest cell-cycle transition at the 
G1/S, intra S and G2/M cell-cycle checkpoint. This is believed to be important in avoiding a 
non-repaired damaged DNA to pass through the checkpoints and also in increasing the time 
available for the repair before replication and mitosis take place. The principal substrate for 
Chk1 is CDC25A, which leads to SCFβTRCP-mediated degradation and activation of intra S 
and G2/M checkpoints (178). At the same time, p53 is the critical substrate of Chk2, which 
promoting stabilization of p53 and subsequent apoptosis when the amount of DSBs is more 
than the system is capable of repairing (179).  
2.4.2.2 Ubiquitin-mediated signaling 
Ubiquitin is a 76 amino acid residues small protein, encoded by four genes in the human 
genome (UBC, UBB, UBA52 and UBA80), which were first described as being fused to 
ribosomal proteins or as linear polyubiquitin chains (180-182). Full-length ubiquitin is a 
precursor peptide that needs to be processed through cleavage to expose the carboxyl-
terminal di-glycine motif that is covalently conjugated through its carboxyl-terminal to the ε-
amino group of the targeted proteins lysine. The conjugation of ubiquitin requires an 
enzymatic process, which is divided to three steps: E1-(activating), E2-(conjugating) and E3-
(ligase) enzymes (183, 184). The number of enzymes involved in the conjugation varies 
greatly among the “E” enzymes. There are eight known E1s of which only two are known to 
be specific for ubiquitin, 35 E2s and a prediction of more than 1000 E3s (185-187). The E3s 
are divided into three families: really interesting new gene (RING), homology to E6AP 
carboxyl-terminus (HECT) and ring between ring (RBR) (187). The RING E3 ligases do not 
contain any catalytic activity and do not interact with ubiquitin directly but rather mediate the 
ubiquitylation by interacting with the E2 and transferring ubiquitin from E2 to the targeted 
substrate. This is done by positioning the ubiquitin into a favorable position for conjugation 
(188, 189). On the other hand, HECT and RBR physically transfer the ubiquitin from E2 to 
its active site cysteine and then to the substrate (190). Some substrates are mono-
ubiquitylated on a single lysine residue while others are multi-mono-ubiquitylated, which 
have been shown to be important in regulating lysosomal degradation of proteins and 
mediating protein-protein interactions (191, 192). Ubiquitin contains seven lysine residues; 
K6, K11, K27, K29, K33, K48 and K63. These residues enable the formation of different 
types of ubiquitin chains and poly-ubiquitylation of substrates, where the type of ubiquitin 
linkages is largely determined by the pairing of specific E2-E3s (190). The majority of the 
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lysine-residue-mediated ubiquitylation labels protein for proteasome-mediated degradation. 
However, K63-linked ubiquitin chains instead mediate protein-protein interactions that are 
particularly important for the DDR (193, 194). 
Ubiquitylation has been shown to regulate almost all DNA repair pathways, especially in 
early signaling following DSBs where BRCA1, 53BP1 and RAD51 are recruited to damaged 
sites in an ubiquitin-mediated manner. K63-linked chains are highly enriched at DNA lesions, 
and the E3 ligase RNF8 is the critical link between phosphorylation and ubiquitylation events 
in the DDR (195-197). RNF8 contains both a RING domain, which is important for E2 
interaction, and a FHA domain that binds phospho-threonine residues, thus facilitating 
interaction with substrates phosphorylated by the PIKKs. The FHA domain of RNF8 
mediates its interaction with MDC1 phosphorylated at its TQXF domain, as previously 
mentioned (195-197). Moreover, WRAP53β mediates the RNF8-MDC1 interaction by 
bringing RNF8 to MDC1 (as discussed in paper I). RNF8 interacts with two other proteins 
that are important for mediating ubiquitylation at DSBs. The E2 ligase ubiquitin-conjugating 
enzyme 13 (UBC13) interacts with RNF8s RING domain, while ATM-phosphorylated 
HECT and the RLD domain containing E3 ubiquitin protein ligase 2 (HERC2), another E3 
ligase, interacts with the FHA domain of RNF8. HERC2 is believed to stabilize the 
interaction between RNF8 and UBC13 and maintain RNF8 levels at DNA lesions (198). 
RNF8 is not the only E3 ligase important in the ubiquitin-mediated recruitment of factors to 
DSBs. The E3 ligase RNF168 is also critical for repair of DSBs and recruited to DNA breaks 
in a RNF8 ubiquitylation-dependent manner. It was originally believed that RNF8 induced 
monoubiquitylation of histone H2A and that this in turn was needed for RNF168 recruitment 
to break sites (199). However, a recent study identified the H1-type linker histones as the 
critical substrate of RNF8. H1 linker histones contain many lysine residues and are 
ubiquitylated under basal conditions. A dramatic increase in K63-linked ubiquitin chains on 
linker histone H1 has been detected upon damage induction was shown to be dependent on 
RNF8 and UBC13. The K63-linked ubiquitylation on H1 linker histones is targeted by 
RNF168, which contains ubiquitin-binding domains known as motifs interacting with 
ubiquitin (MIU). This mediates its binding to K63-linked conjugates on H1 linker histones. 
From here, RNF168 in turn catalyzes the formation of K27-linked ubiquitin chains on lysine 
13 and 15 of histone H2A and H2AX, which is important for the recruitment of 53BP1, 
receptor-associated protein 80 (RAP80) and BRCA1 (200-203).  
Interestingly, RNF8 can also interact with the E2 ubiquitin-conjugating enzyme UBCH8, 
which promote K48-linked polyubuiquitylation of several substrates such as Ku80, the 
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demethylase jumonji domain 2A (JMJD2A) and the polycomb protein lethal(3)malignant 
brain tumor-like 1 (L3MBTL1) where the two later proteins binds with and masks the 
H4K20m2 (204-206). The ubiquitin-selective chaperone/segregase VCP/p97 facilitate 
ubiquitin-dependent extraction of chromatin-associated proteins such as L3MBTL1 and 
expose histone H4K20me2, which is important for 53BP1 recruitment (206).  
The ubiquitin-mediated signaling response is attenuated or turned off by the action of  
deubiquitylating enzymes (DUBs) and approximately 100 DUBs are encoded by the human 
genome (207, 208). Several DUBs function to limit RNF8 and RNF168-mediated 
ubiquitylation. The ubiquitin-specific proteases 3 and 16 (USP3 and USP16) both catalyze 
the disassembly of RNF8 and RNF168-generated ubiquitin chains (209, 210). The OUT 
domain ubiquitin aldehyde-binding 1 (OTUB1) inhibits UBC13 by a direct interaction and 
consequently limits the RNF8 and RNF168 ubiquitylation (211). The BRCA1/BRCA2-
containing complex subunit 36 (BRCC36), on the other hand, specifically catalyzes the 
removal of the K63-linked ubiquitin chains mediated by RNF8 and UBC13 (212). It is also 
noteworthy that an E3 ubiquitin ligase paralogous to RNF168 called RNF169 acts as a 
negative regulatory of RNF168-catalyzed ubiquitylation products by competing with 53BP1 
and BRCA1 for binding the ubiquitin chains eventually limiting the magnitude of their 
recruitment to DNA lesions (213). 
53BP1 is a 1972 amino acid large protein that contains BRCT repeats, a tandem Tudor 
domain and 28 amino-terminal S/T-Q site which is phosphorylated mainly by ATM (214). As 
mentioned earlier, 53BP1 targets H4K20me2 that has previously been exposed in a RNF8-
mediated fashion and this interaction is dependent on the tandem Tudor domain of 53BP1. 
Albeit the interaction to H4K20me2 is necessary for 53BP1 recruitment, it is not sufficient 
for its focal accumulation at DNA lesions, suggesting an additional binding site of 53BP1 
(215). As mentioned earlier, 53BP1 interacts with RNF168 ubiquitin chains and more 
specifically is highly selective for H2AK15ub through its ubiquitylation-dependent 
recruitment (UDR) motif located adjacent to the tandem Tudor domain (216). Mutation in the 
UDR motif impaired 53BP1 focus formation and abolished the interaction with H2AK15ub 
but not to H4K20me2, which indicates that the binding to H4K20me2 is RNF168 
independent. This finding thereby confirms the RNF8-UBCH8 mediated H4K20me2 
exposure for 53BP1 (205, 206, 216). Interestingly, 53BP1 must be present at least as a dimer, 
and it binds to mononucleosomes containing both H2AK15ub and H4K20me2 marks. The 
BRCT repeats are thought to be dispensable, but recently, a research group used quantitative 
chemical proteomics to identify 53BP1 BRCT repeats to be binding γH2AX. They detected 
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that the interactions of 53BP1 with H4K20me2 and H2AK15ub are in general very weak 
bindings. Therefore, 53BP1’s localization to damaged sites relies upon multiple interactions 
where no single epitope provides sufficient interaction energy for stable association. 
However, it is believed that the interaction of 53BP1 with γH2AX occurs in a specific context 
such as DNA lesions in late repairing heterochromatin regions (217, 218).   
BRCA1 is a 1863 amino acid large protein with three regions: a RING domain in the N-
terminus (a large unstructured region), a coiled-coil domain and tandem BRCT repeats in the 
C-terminus (219). These three different regions enable the protein to create three binding 
complexes: BRCA1-A, BRCA1-B and BRCA1-C, where each complex implicates BRCA1 
in different multiple cellular functions such as transcription, cell cycle checkpoint activation 
and DNA repair, most importantly in the HR pathway (Figure 7) (220, 221). The BRCA1 
RING domain interacts with the BRCA1-associated RING protein 1 (BARD1), forming a 
heterodimer, which is important for their mutual stability and this complex is present in all 
BRCA1 sub-complexes (222-224). The heterodimer can direct both mono- and 
polyubiquitylation depending on the interacting E2 conjugating enzyme (225). Moreover, 
they catalyze the formation of non-canonical lysine-6 linked ubiquitin chains (K6-polyUb), 
which serves as a signaling mechanism for protein complex assembly and/or protein 
stabilization. These chains are also important for the accumulation of BRCA1 itself and the 
end resection factor CtIP at DNA lesions (226-228). In the BRCA1-A complex, BRCA1 
interacts directly with a protein termed Abraxas through its BRCT repeats in a 
phosphorylation-dependent manner, which also facilitates binding to RAP80, another 
BRCA1-A complex component. RAP80 recognizes and interacts with K63-polyubiquitylated 
chains, mediating the recruitment of BRCA1 to the DNA lesions for repair and also causing 
inhibition of end resection (229-231). Moreover, the complex consists of several other 
proteins related to the DUB proteins that provide deubiquitylation important for the 
regulation of protein dynamics at DNA lesions (Figure 7) (232). In the BRCA1-B complex, 
BRCA1 binds to Bach1 that is phosphorylated by CDK on S990 in a cell cycle dependent 
manner. This complex formation is required for S-phase activation during stalled or collapsed 
replication forks (233-235). Bach1 interacts with TopBP1 that is required for replication-
induced checkpoints and also for the extension of single-stranded DNA and RPA loading 
following replication stress (Figure 7) (236). The BRCA1-C complex is required for DNA 
end resection and entails CtIP that is phosphorylated at S327 by CDKs in a cell-cycle 
dependent manner during S and G2 phase. The phosphorylated S327 site is required for 
binding to the BRCT domain of BRCA1. CtIP also brings the MRN complex to the BRCA1-
C complex by interacting with the NBS1 subunit of the MRN complex. It thereby stimulates 
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the nuclease activity of the MRN complex in order to promote DNA end resection for HR-
mediated DSB repair (Figure 7) (234, 237). As mentioned above, all BRCA1 complexes 
(e.g., A-C) are formed through the BRCT repeats of BRCA1. On the other hand, the coiled 
coil domain of BRCA1 is an important binding site for the WD40 partner and localizer of 
BRCA2 (PALB2), which acts as a bridge mediator between BRCA1 and BRCA2 (238-241). 
BRCA2 in turn interacts with RAD51 and promotes its loading to the resected ssDNA for 
efficient HR repair (Figure 7) (242). 
 
Figure 7: An illustration of the different BRCA1 complexes with their interaction partners and function. 
Even though, RAD51 is recruited through the BRCA1-C complex, it is still dependent on 
RNF8 ubiquitylation where RAD51 recruitment has been shown to be impaired upon RNF8 
knockdown while unaffected or modestly affected upon RNF168 knockdown and also in 
RIDDLE syndrome cells with mutated RNF168, respectively (243-245). Additionally, 
RAD51 recruitment to DNA lesions is RNF8 dependent upon replication. Thus, the 
recruitment is possibly dependent on K48-linked ubiquitin chains mediated by RNF8 and not 
through the K63-linked ubiquitin chains mediated by RNF8/Ubc13/RNF168 (204, 246, 247). 
However, the full mechanism in RNF8 dependent RAD51 recruitment is yet not fully 
understood. Nonetheless, RAD51 replaces RPA at resected ssDNA in a mechanism 
dependent on RNF8- and RNF4-mediated recruitment of the proteasomal component PSMD4 
and through the E3 ligase RNF18, which interacts with RNF8-generated ubiquitin chains and 
thereby mediates the recruitment of its binding partner RAD51C, a RAD51 paralog that is 
necessary for RAD51 foci formation. It has also been suggested that RAD51 is recruited only 
in the absence of 53BP1 and BRCA1 (175, 248, 249). A summarized schematic scheme of 
the damage response is illustrated in figure 8.  
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Figure 8: A schematic illustration of the DDR. 1) The MRN complex is recruited to the DNA ends, brining 
ATM with them. 2) ATM phosphorylates H2AX, which interacts with MDC1. 3) WRAP53β recruits RNF8 to 
MDC1. 4) RNF8 ubiquitylates, through its E2 ligase, H1-linker histone, L3MBTL1 and JMJD2A, thus 
promoting the degradation of L3MBTL1 and JMJD2A leading to exposure of H4K20me2 thereby creating the 
docking site for 53BP1. In addition, RAD51 is also recruited. 5) Ubiquitylated H1-linker histone is recognized 
by RNF168 that further ubiquitylates H2A and H2AX facilitating the recruitment of 53BP1 and BRCA1-A 
complex.  
2.4.3 Repair of DNA double-strand breaks  
2.4.3.1 Homologous recombination  
HR repairs DSBs through several sub-pathways. Additionally, HR function in the repair of 
collapsed replication forks and also in maintaining the chromosome ends by promoting 
telomere recombination (115).  
HR-mediated repair is divided into three stages: pre-synapsis, synapsis and post-synapsis. In 
the pre-synapsis, DNA ends are processed 5’ to 3’ in order to create a 3’ ssDNA overhang, 
which is initially bound by RPA and then replaced by RAD51 (250). The processing is 
mediated by four nucleases (the MRN complex, Exo 1, Dna2, and CtIP) and the helicase 
BLM, where the MRN complex together with CtIP initiates resection and degrade a part of 
the broken 5’DNA. The DNA is further processed more extensively by Dna2, Exo 1 and 
BLM (251). RPA bound to the ssDNA restricts RAD51 assembly to DNA, and therefore, 
RPA becomes displaced through two different classes of mediators in human cells. The first 
class of mediators is comprised of the RAD51 paralogs: RAD51B, RAD51C, RAD51D, 
XRCC2 and XRCC3. The second class is mediated through BRCA2 (252, 253). These 
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factors are all important for presynaptic RAD51 filament formation and stability, however the 
precise mechanism of action of the mediator proteins is poorly understood. 
During synapsis, the RAD51-ssDNA filament performs a homology search by invading an 
intact DNA molecule, also generating a D-loop where the invading stand primes DNA 
synthesis. The RAD54 motor protein is required for RAD51 filament stabilization and D-loop 
enhancement but is especially important for dissociating RAD51 from heteroduplex DNA 
and enabling the transition from DNA strand invasion to DNA synthesis (254).  Finally, in 
the post-synaptic stage, four different sub-pathways of HR are distinguished to repair DNA 
lesions.  
The double strand break repair (DSBR) sub-pathway creates a so-called double Holliday 
junction (dHJ) by generating four-stranded DNA structures that is dissolved in two different 
ways. The dHJ is cleaved into crossover or non-crossover products by several structure 
specific endonucleases such as: ERCC1-XPF, MUS81-EME1, GEN1 and SLX1-SLX4 (255-
257). The non-crossover product keeps its parental configuration, and the two dHJ may 
migrate towards each other through branch migration. This item is then dissolved by the 
topoisomerase complex BLM-TOPOIIIα-RMI1/RMI2. The crossover product, on the other 
hand, produces an exchange of flanking genetic materials with the duplex DNA (258, 259).  
In synthesis-dependent strand annealing (SDSA), only non-crossover products are produced 
by dissolving the D-loop where the invading strand is disengaged after DNA synthesis and 
annealed with the second end. However, the process may require multiple rounds of invasion, 
synthesis and disengagement. Break-induced replication (BIR) repairs DSBs that have only 
one free end by assembling the D-loop into a fully established replication fork to copy the 
entire distal fragment (260). Conversely, the single-strand annealing (SSA) is a RAD51-
independent pathway where DSBs with two ends are flanked by repeated sequence. The 
repair is instead dependent on RAD52 and RPA by annealing to homologous ssDNA 
sequences during 5’ end resection and then ERCC1-XPF processes the remaining 3’ flap 
overhangs (Figure 9) (261).  
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Figure 9: Illustration of the Homologous recombination repair pathway. A) The initial steps of HR repair, red 
represents damaged DNA and blue the template DNA. B) DSBR, the products of non-crossover and crossover 
are marked in dashed box. C) SDSA. D) BIR. E) SSA.     
2.4.3.2 Non-homologous end joining  
The NHEJ repair pathway is characterized by rejoining broken DNA ends without using a 
template, which enables this pathway to be active throughout the cell cycle and therefore is 
the predominant repair pathway for DSBs in humans (262). This repair pathway is considered 
to be error prone since it does not utilize a template for restoring any DNA sequence that has 
been lost upon damage. However, if the lesion is broken with blunt ends where no end 
processing is required, the DNA sequence might be restored. Conversely, in the absence of 
clean breaks and or in the presence of base and sugar damage, end processing may be 
required, which may led to mutagenic events due to loss or gain of genetic sequences (263). 
NHEJ is divided into five stages: 1) recognition of breaks by Ku, 2) synaptic end bridging, 3) 
DNA end processing, 4) ligation of breaks and 5) Ku removal from repaired DNA (128).  
As mentioned earlier, Ku is the sensor for recognizing DSBs intended in NHEJ repair. Ku is 
highly abundant with about 500,000 molecules in each human cell with a very strong affinity 
to DNA ends, recruited within 5s post damage (127). Ku is enriched via its central ring 
domain where it acts as a scaffold for the entire NHEJ complex. It has been unclear how 
many Ku molecules are recruited to DSBs. However, recent development in visualizing Ku 
foci revealed that 2 Ku molecules are recruited to a DSB, one at each end (264). Once 
attached to the DNA, DNA-PKcs are recruited to lesions and directly interacts with Ku80 
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through both the N and C terminals of DNA-PKcs (265). Interaction then initiates an active 
complex, in which Ku starts to translocate and allows DNA-PKcs to be placed at the tip of 
the end. This allows for synaptic joining of the two ends and stabilization of the complex 
(266). Additionally, activated DNA-PKcs leads to 15 auto-phosphorylation events and also 
the phosphorylation of several other NHEJ factors including Ku70/80 in vitro (267, 268).  
 
Figure 10: Schematic illustration of non-homologous end-joining repair pathway.  
Between the break recognition by Ku and the final ligation of the break, there is considerable 
flexibility in factors involved in the repair, which depends on the type of damage. For 
example, IR induces several different kinds of damage and also produces non-ligatable 3’-
phosphate groups, 3’-phosphoglycolates or 5’-hydroxyl groups. Therefore, several factors are 
required to process the ends, which involve kinases and phosphatases (polynucleotide 
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kinase/phosphatase (PNKP)), nucleases (Werner, Mre11, Artemis, ExoI), polymerases (DNA 
polymerases m and I), helicases (RECQ1) and phosphodiesterases (tyrosyl-DNA 
phosphodiesterase 1) (128, 136). Meanwhile, topoisomerase II-induced damage leads to 
physical incorporation of topoisomerase II to the 5’terminus, which requires the specific end-
processing enzyme tyrosyl DNA phosphodiesterase 2 (TDP2) by hydrolyzing the 
topoisomerase II interaction (269, 270). Following end processing, the ends are fused 
together with help of ligation factors such as DNA ligase IV, X-ray repair cross-
complementing protein 4 (XRCC4) and XRCC4-like factor (XLF). These elements are 
subsequently recruited to Ku, forming a heterodimer complex where XRCC4 interacts 
directly with the Ku70 (271-274). When damage is repaired, Ku needs to be removed since it 
encircles the DNA and is literally trapped. Several possible mechanisms in Ku removal have 
been proposed. It has been suggested that K48-ubiquitin-linked chains on Ku mediated by 
RNF8 promote Ku degradation and RNF8 knockdown leads to increased Ku80 retention at 
breaks and decreases NHEJ efficiency (204). However, recent studies have implied that it is 
not RNF8 but instead NEDD8 that ubiquitylate Ku (figure 10) (275).  
2.4.3.3 53BP1 and BRCA1 regulation of repair pathway choice 
53BP1 and BRCA1 have shown to be essential for the selection of a repair pathway. It has 
been observed in BRCA1-deficient cells that 53BP1 inhibits HR by blocking the resection of 
DSBs, which leads to an aberrant repair by NHEJ. Fascinatingly, the loss of 53BP1 in the 
BRCA1-deficient cells rescues the disease phenotypes associated with BRCA1 deficiency 
and restores the RAD51 foci and HR repair (276, 277). The 53BP1 NHEJ promotion is 
strictly dependent on its interaction with RIF1 in a DNA damage-dependent manner (278). 
The 53BP1-RIF1 accumulation at DSBs prevents the BRCA1-CtIP recruitment in G1 thereby 
inhibiting end resection. Therefore, BRCA1-CtIP (BRCA1-C) recruitment is restricted to the 
S/G2 phase of the cell cycle where they in turn inhibit RIF1 recruitment by promoting 
resection of DSB ends. Even though 53BP1 accumulates in DSB-induced foci during G1, S 
and G2 phase, super-resolution microscopy analysis has shown that 53BP1 and RIF1 have 
been evicted from the focal core during S phase in a BRCA1-dependent manner (279-281).  
2.4.4 Detection and visualization of DNA double-strand breaks 
2.4.4.1 IR-induced foci  
Genotoxic agents such as topoisomerase inhibitors, H2O2, radiomimetic drugs and IR induce 
DNA damage that promotes the accumulation of many factors at the site of damage leading 
to the formation of cytological discernable foci (282-284). Such foci can be detected by 
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indirect immunofluorescence with antibodies against the protein of interest or in real time by 
live imaging with fluorescently tagged proteins. Factors forming IR-induced foci (IRIF) 
normally overlap with γH2AX foci indicating that they form around the damage site. The 
numbers of foci increase in a dose-dependent manner and it has been estimated that around 
20-40 foci are formed per gray of irradiation in human cells and corresponds to 
approximately 20-40 breaks. Additionally, changes in size and the number of foci throughout 
the repair time can be visualized (285).  
2.4.4.2 Laser micro-irradiation  
The development of laser micro-irradiation (LMI) enabled the study of factors that do not 
form IRIF and also the study of spatiotemporal accumulation of repair factors at DNA breaks. 
There are several types of LMI, each using different energy sources to induce damage such as 
alpha particles, energetic-heavy ions, UV-A laser, two-photon laser, YAG laser and confocal 
laser. The UV-A laser is the preferred choice, since the dose range is very close to the 
damage induced by IR (286). LMI is based on a microscope system equipped with a UV-A 
laser with a wavelength between 337-390 nm. Cells are pre-sensitized to the UV-A light by 
low levels of either halogenated thymidine analogs (BrdU, IdU) and/or DNA intercalating 
dyes (Hoechst 33258), which upon UV-A exposure, results in a photochemical reaction that 
generates DSBs (287).  
2.4.4.3 Proximity ligation assay  
Proximity ligation assay (PLA) is a method to detect individual proteins or protein-protein 
interactions in fixed cells with amplified signals (288). The method is performed in 4 steps: 
1) targeting your protein or proteins of interest using conventional antibodies, 2) targeting the 
primary antibodies using secondary antibodies tagged with oligonucleotide probes, 3) if the 
antibodies are in close proximity of each other, the oligonucleotides will hybridize with two 
connector probes and upon ligation form a circular DNA molecule that can be amplified via 
rolling circle amplification, and 4) the ssDNA molecule produced by rolling circle 
amplification can be labeled with fluorescently complementary oligonucleotides, which can 
be detectable using a fluorescence microscope (Figure 11) (289).  
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Figure 11: Schematic illustration of the proximity ligation assay. 1) Targeting proteins with conventional 
antibodies. 2) Secondary antibodies tagged with probes targets the primary antibodies. 3) Probes hybridize, 
which forms a circular DNA structure that then is amplified. 4) The circular DNA is with labeled with 
fluorescently complementary oligonucleotides 
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3 AIM OF THIS THESIS 
The overall aim of this thesis was to characterize the role of WRAP53β in the DDR.  
Specific aims of the papers: 
I. To elucidate the role of WRAP53β in the DDR 
II. To gain a deeper insight into the role of  WRAP53β in DDR by using PLA  
III. To study the function of overexpressed WRAP53β in carcinogenesis  
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4 RESULTS AND DISCUSSION 
4.1 PAPER I – THE SCAFFOLD PROTEIN WRAP53β ORCHESTRATES THE 
UBIQUITIN RESPONSE CRITICAL FOR DNA DOUBLE-STRAND BREAK 
REPAIR 
Several independent studies have implicated WRAP53β in the DDR. A large-scale proteomic 
analysis of ATM and ATR substrates in response to DNA damage revealed that WRAP53β is 
such a substrate (135). A genome-wide siRNA screen for identifying new genes involved in 
genome stabilization by monitoring γH2AX formation revealed the involvement of 
WRAP53β in preserving genomic stability (290). Moreover, in another genome-wide siRNA 
screen designed to identify factors involved in the HR repair pathway using the I-SceI 
endonucleus GFP-based reporter assay, WRAP53β was found to be an important factor for 
HR (291, 292). Furthermore, inherited mutations in WRAP53β cause the cancer 
predisposition disorder dyskeratosis congenita and altered expression of WRAP53β or SNPs 
in this gene have been associated with an increased risk of sporadic tumors such as breast and 
ovarian cancer, radioresistant head and neck cancer and altered DNA repair in patients with 
benzene-induced hematotoxicity (93, 101-103, 293, 294).  
To explore the involvement of WRAP53βs in DDR, we initially used LMI to elucidate 
whether WRAP53βs is recruited to DNA breaks. WRAP53β accumulated at DNA lesions 
within minutes after LMI, indicating that WRAP53βs is high upstream in the DDR cascade. 
Although many WRAP53β antibodies showed localization of this protein at LMI-induced 
stripes, only one revealed IRIF of WRAP53β, which clearly overlapped γH2AX foci and had 
similar IRIF kinetics as γH2AX over a 24 h-period. To investigate how WRAP53β 
accumulates at DSB, we individually inhibited the three kinases in the PIKKs family: ATM, 
ATR and DNA-PK. ATM inhibition significantly impaired WRAP53β recruitment to DNA 
lesions, while ATR inhibition partially abrogated this recruitment. DNA-PKcs inhibition did 
not have any effect. This indicates that the recruitment of WRAP53β to DNA breaks is 
ATM/ATR dependent. Additionally, the recruitment of WRAP53β was impaired by 
knockdown of H2AX and MDC1. To study the spatiotemporal dynamics of WRAP53β, we 
used the I-PpoI homing endonuclease to induce DSBs at defined sites (295). It is noteworthy 
that WRAP53β accumulated not only at the break site but also in the surrounding region, up 
to 6 kb away from the damage site.  
As the recruitment of WRAP53β has been established to be dependent on 
ATM/ATR/γH2AX/MDC1, we set out to pinpoint its localization in the DDR cascade. We 
knocked down WRAP53β and studied the formation of IRIF of several DDR factors. The 
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IRIF formation of the repair proteins 53BP1, BRCA1 and RAD51 were impaired, while 
γH2AX and MDC1 were unaffected. Furthermore, the E3 ligase RNF8 and RNF168, which 
are responsible for the repair factors to be recruited in an ubiquitylation-dependent manner, 
showed impaired in IRIF formation upon WRAP53β knockdown. In addition, the IRIF 
formation of conjugated ubiquitin at DNA breaks by RNF8 and RNF168, and the levels of 
ubiquitinylated H2AX were reduced in cells lacking WRAP53β.  
Since WRAP53β is required for recruitment of RNF8 to DNA damage sites and downstream 
ubiquitylation, but does not interfere with accumulation of the upstream MDC1 protein, it 
appears like WRAP53β is acting at a step between MDC1 and RNF8. Therefore, we set out 
to determine the biochemical function of WRAP53β in RNF8 and MDC1 complex formation. 
We discovered that WRAP53β interacts with both RNF8 and MDC1 using co-
immunoprecipitation and these interactions were enhanced upon irradiation. To further 
pinpoint the exact interaction sites between the proteins, we generated deletion constructs of 
MDC1, RNF8 and WRAP53β. This showed that WRAP53β interacts with the FHA domains 
of both RNF8 and MDC1. Since MDC1 also interacts with the FHA domain of RNF8, we 
further explored what part of this domain that is involved in the interactions with MDC1 and 
WRAP53β, revealing that WRAP53β interacts with amino acids 1-38, while MDC1 interacts 
within amino acids 39-140 of the RNF8 FHA domain.  
Using deletion constructs of WRAP53β, we found that both MDC1 and RNF8 bound to the 
WD40 domain of WRAP53β. By dividing the WD40 domain into different combinations of 
repeats, we could detect that both RNF8 and MDC1 preferably interacted with repeats 2 and 
3.  
We next set out to study whether WRAP53β regulates the complex formation between 
MDC1 and RNF8 by examining the organization of interaction between WRAP53β, γH2AX, 
MDC1 and RNF8. By knocking down each factor separately, followed by 
immunoprecipitation of WRAP53β we found that the interaction between WRAP53β and 
MDC1 is independent of RNF8 and H2AX, and that the interaction between WRAP53β and 
RNF8 is independent of MDC1 and H2AX. In contrast, the interaction between RNF8 and 
MDC1 is dependent on WRAP53β. Since ATM phosphorylation of MDC1 is known to be 
required for MDC1-RNF8 interaction, we examined whether WRAP53β influences this 
process. However, phosphorylation of MDC1 by ATM occurred independent of WRAP53β, 
indicating that WRAP53β does not mediate this process. Instead, it appears like WRAP53β 
by simultaneous binding of MDC1 and RNF8 via its WD40 domain bring these proteins in 
close proximity, thus facilitating the direct interaction between MDC1 and RNF8.  
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To further elucidate the significance of WRAP53β for DSB repair, we knocked down this 
protein and analyzed clearance of γH2AX foci after irradiation. Indeed, a significant amount 
of γH2AX IRIF was still present 24 hours post irradiation in cells lacking WRAP53β, 
indicating that DSBs are left unrepaired in the absence of WRAP53β. As mentioned above, 
DSBs are repaired by NHEJ and HR and to study WRAP53β’s involvement in these repair 
pathways, the I-SceI endonucleus based GFP reporter assay for HR and NHEJ repair 
efficiency was used. Knockdown of WRAP53β severely affected the efficiency of both HR 
and NHEJ repair. Additionally, in the absence of WRAP53β, irradiated cells showed a 
delayed recovery from G2/M arrest due to deficient DNA repair.  
Furthermore, non-irradiated cells developed spontaneous γH2AX IRIF when WRAP53β was 
knocked down and accumulated more DSBs when analyzed using the comet assay, 
demonstrating that WRAP53β is important for genomic stability.  
In this study, we have demonstrated that WRAP53β is a novel regulator of DSB repair by 
scaffolding RNF8 and MDC1 interaction, which enable ubiquitylation of damaged chromatin 
and facilitates downstream recruitment of necessary factors.  
Nonetheless, several questions remain to be answered. For example, how can both 
WRAP53β and MDC1 bind the same FHA domain of RNF8? RNF8 interacts with a 
chromatin helicase DNA-binding protein 4 (CHD4), which is the catalytic subunit of the 
nucleosome remodeling and histone deacetylation (NuRD) complex. This is important for 
chromatin decondensation at DSBs. CHD4 is recruited to DNA lesions in a non-catalytic 
fashion through a phospho-independent function of the RNF8 FHA domain and mediates 
decondensation, which is important for the recruitment of repair factors (296). Are these 
proteins binding different parts of the FHA domain or do they compete for binding? There 
are two different predictions for the size of the RNF8 FHA domain: amino acids 13-140 or 
amino acids 17-111 and amino acids 130-140 has been shown to form an α helical extension 
(196, 197, 296). We found that an internal deletion construct of RNF8 lacking amino acids 
39-109 of the FHA domain only disrupted binding to MDC1, while the binding to WRAP53β 
was intact. With this knowledge, we conclude that at least MDC1 and WRAP53β interact 
within different amino acids of the RNF8 FHA domain. Possibly, CHD4 is binding between 
WRAP53β and MDC1, but unfortunately, we have not investigated this matter yet.  
RNF8 mediates both K48- and K63-linked ubiquitin chains depending on its interaction with 
the responsible E2 conjugating enzyme. The FK2 antibody used for detecting conjugating 
ubiquitin showed a severe decreased accumulation of ubiquitylation at DNA damage sites 
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when WRAP53β was knocked down. This FK2 antibody detects K29-, K48- and K63-linked 
mono and polyubiquitin chains and the loss of FK2 foci indicates that WRAP53β is important 
for both K48 and K63 ubiquitylation by RNF8. In accordance, 53BP1 recruitment, known to 
be dependent on both K48- and K63-linked ubiquitin chains, was lost when WRAP53β was 
knocked down.   
WRAP53β is a multifunctional protein acting in several different cellular compartments: in 
the cytoplasm, Cajal bodies and at telomeres. It is possible that different posttranslational 
modification of WRAP53β targets this protein to the right compartment. Indeed, the 
ATM/ATR substrate screening study showed that WRAP53β is a substrate and we have 
confirmed this phosphorylation site of WRAP53β at serine 64 (data not shown). 
4.2 PAPER II – THE PROXIMITY LIGATION ASSAY REVEALS THAT AT DNA 
DOUBLE-STRAND BREAKS WRAP53β	ASSOCIATES WITH γH2AX AND 
CONTROLS INTERACTIONS BETWEEN RNF8 AND MDC1  
Several DDR-related proteins especially those involved in NHEJ cannot form detectable IRIF 
(264). In paper II we introduce PLA in the DDR field to monitor repair proteins and obtained 
deeper insight of WRAP53β’s involvement in the DDR cascade.  
To assess whether the PLA method is applicable in the DDR field, we used this method to 
detect γH2AX and MDC1 interaction upon irradiation. Interestingly, several PLA signals 
were detected upon irradiation in a very similar pattern as the foci formation of these proteins, 
while no signals were acquired in non-irradiated cells. The method is both specific and 
sensitive, since the number of signals was reduced upon knockdown of H2AX or MDC1 or 
ATM inhibition. Similar results were obtained for the 53BP and γH2AX, and in combination 
with LMI, PLA signals could be detected along the laser stripes.  
Since, the PLA method clearly could detect proteins at DNA lesions, we set out to challenge 
the method even further by studying WRAP53β association with γH2AX using a WRAP53β 
antibody that does not detect IRIF of this protein. Interestingly, PLA signals were detectable 
upon irradiation, confirming the findings from paper I that WRAP53β accumulates at DNA 
lesions and moreover, that WRAP53β associates with γH2AX. In addition, the WRAP53β-
γH2AX association was detected at LMI induced stripes.  
To confirm the specificity of the WRAP53β- γH2AX association, we immunoprecipitated 
WRAP53β and γH2AX separately and indeed, they interacted with each other in two 
different cell lines and the interaction was enhanced upon irradiation. By using different 
deletion and mutation constructs, we mapped their interaction. γH2AX did not interact with 
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WRAP53β deletion constructs containing only the N-terminus, the WD40 domain or the C-
terminus. Neither did it bind ΔN149 or ΔC93 variants of WRAP53β, or the DC missense 
mutants of WRAP53β (F164L, H376Y, R398W, G435R). However, γH2AX did bind 
WRAP53β protein lacking 15 amino acids in its C-terminus (ΔC15). This indicates that the 
interaction with γH2AX requires wild type WRAP53β and proper TRiC-dependent folding of 
WRAP53β. Moreover, the WRAP53β-γH2AX association was ATM and ATR dependent, in 
line with the requirement of ATM/ATR for accumulation of WRAP53β at DSBs (paper I).  
Using PLA, we also confirmed our data in paper I regarding the regulation of RNF8 and 
MDC1 interaction by WRAP53β. The endogenous RNF8 protein does not form visible IRIF 
and cannot be detected by immunoprecipitation and for that reason we used overexpressed 
RNF8, which forms foci and co-immunoprecipitates with WRAP53β, in paper I. In paper II, 
we could visualize the association between WRAP53β and endogenous RNF8 in irradiated 
cells using PLA. The same method also showed association between WRAP53β and MDC1 
in irradiated cells. Using PLA, we also confirmed that the association between MDC1 and 
RNF8 was lost in WRAP53β deficient cells or upon ATM inhibition and that the 
phosphorylation of MDC1 appeared intact in cells lacking WRAP53β, since the MDC1-
pATM association was unaffected by WRAP53β knockdown.  
Our finding that the interaction between WRAP53β and γH2AX is independent of MDC1, 
while the foci formation of WRAP53β depends on MDC1, indicates that WRAP53β may be 
recruited to DSBs by two independent mechanisms. Indeed, WRAP53β accumulates both at 
the actual cut site of a DSB, which is typical for NHEJ factors and a region often lacking 
γH2AX, as well as in in the surrounding region of the breaks, which is characteristic for HR 
proteins and a region containing γH2AX (paper I). The retention time of WRAP53β at the 
actual break site was furthermore longer compared to the binding of WRAP53β at the more 
distal regions. This indicates that these different pools of WRAP53β are regulated differently, 
however the underlying mechanism(s) and whether WRAP53β has additional roles at the 
break site remains to be elucidated.  
4.3 PAPER III – OVEREXPRESSION OF THE SCAFFOLD WD40 WRAP53β 
ENHANCES REPAIR AND CELL SURVIVAL FROM DNA DOUBLE-
STRAND BREAKS 
Tumors exhibiting altered responses to DNA damage and are affected very differently by 
genotoxic drugs, being either hypersensitive or resistant. In most cases, inactivation of DDR 
factors results in radiosensitivity of the tumor due to loss of DNA repair (297). Indeed, 
altered expression of WRAP53β is linked to both carcinogenesis and radioresistance (93, 95-
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97). Here, we examined the potential influence of WRAP53β overexpression on the DNA 
damage response and sensitivity to DNA damaging agents. 
In cells that stably overexpress WRAP53β, we could detect that WRAP53β is overexpressed 
both in the cytoplasm and nucleus using immunofluorescence. Chromatin fractionation 
further showed that the majority of overexpressed WRAP53β is in soluble form and only 
slightly elevated in the chromatin fraction. This finding may explain why Cajal bodies are 
collapsed in cells overexpressing WRAP53β, while the function of this protein in DNA repair 
is intact.  
Interestingly, we found that overexpression of WRAP53β enhanced DSB repair using several 
methods. First, the clearance of γH2AX foci was faster in cells overexpressing WRAP53β 
compared to cells with endogenous levels of WRAP53β. Second, comet assay revealed fewer 
DNA breaks after irradiation in WRAP53β overexpressing cells, in accordance with faster 
repair. Finally, the repair efficiency of both HR and NHEJ repair was enhanced in cells 
overexpressing WRAP53β.  
We could also link the increased efficiency in DNA repair to RNF8 in cells overexpressing 
WRAP53β, since these cells showed enhanced RNF8-mediated ubiquitylation of H2AX and 
overexpression of RNF8 itself elevated NHEJ and HR repair to a similar extent as 
overexpression of WRAP53β. We propose that overexpression of WRAP53β may increase 
the level of RNF8 in repair foci by tethering it to damaged chromatin, thus slowing down its 
otherwise rapid turnover and promoting ubiquitylation.  
Furthermore, WRAP53β overexpressing cells are resistant to irradiation and several other 
DNA damaging agents, possibly due to more rapid repair, which raises the possibility that 
upregulation of WRAP53β may contribute to genomic stability in and survival of cancer 
cells. 
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